Clinical research - Press Releases

Date	Title	Company
10-Oct-2023	Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention	Innovative Trials
10-Oct-2023	Life sciences leaders unite to condemn radical plans to rewrite medicines scheme	British Pharmaceutical Industry (ABPI)
10-Oct-2023	Brandon Capital Joins AstronauTx’ £48 million ($61 million) Series A Financing to Create New Treatments for Alzheimer’s disease	Brandon Capital
10-Oct-2023	Pheon Therapeutics Appoints Oncology Expert Arvin Yang, MD, PhD as Chief Medical Officer	Pheon Therapeutics
10-Oct-2023	Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award	Novotech
10-Oct-2023	LYNPARZA (OLAPARIB) ACCEPTED FOR USE IN SCOTLAND AS ADJUVANT TREATMENT FOR PATIENTS WITH GERMLINE BRCA-MUTATED HER2-NEGATIVE HIGH RISK EARLY BREAST CANCER	AstraZeneca
10-Oct-2023	Elsevier launches new PharmaPendium, empowering pharma companies to bring novel drugs to market faster and increase success of regulatory submissions	Elsevier
10-Oct-2023	Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies	Cryoport, Inc
10-Oct-2023	Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications	Creative Diagnostics
10-Oct-2023	Creative Diagnostics Launches Checkerboard Assay Services	Creative Diagnostics
10-Oct-2023	Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development	Creative Diagnostics
05-Oct-2023	Veranova Announces Appointment of New Advisory Board	Veranova
05-Oct-2023	UK Launches Its First National Total-Body PET Platform for Drug Discovery	Medicines Discovery Catapult
04-Oct-2023	Phastar Net-Zero Target Approved by the Science Based Targets Initiative	Phastar
04-Oct-2023	CTMC partners with ScaleReady to automate, close, and scale for greater patient accessibility	ScaleReady
04-Oct-2023	PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation	PureTech Health plc
04-Oct-2023	Myricx Expands its ADC Expertise with the Appointment of Francesca Zammarchi as CSO	Myricx
04-Oct-2023	Rejuvenate Biomed announces positive results from Phase 1b clinical trial with RJx-01 in sarcopenia	Rejuvenate Biomed NV
04-Oct-2023	Novotech Appoints Dr. Judith Ng-Cashin as Chief Medical Officer to Drive Global Medical Services	Novotech
04-Oct-2023	Advent International and Warburg Pincus Complete Acquisition of Baxter’s BioPharma Solutions Business	Advent International